Sign in
Taking peoplePhase 1

NON-IV: Neo-adjuvant peritumOral immuNotherapy In Vulvar cancer

Key facts

Who runs it
Amsterdam UMC Stichting
Where
Netherlands2 sites in 1 countryChoose a country to see its sites
Status
Recruiting
Phase
Phase 1
People taking part
24 people, planned
Started
4 Feb 2026
Expected to end
1 Aug 2027
Type of study
Interventional
Record updated
16 December 2025

Who can take part

Age
18 years to 64 years
Sex
Women only
Healthy volunteers
Cannot take part

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Vulvar cancer

This trial is currently available in Netherlands.

It has sites in one country. Choose a country to see its sites.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Criteria questions
Built from 2025-520712-34-00, who can take part
Record updated
16 December 2025